Hospital Universitario Araba-ko ikertzaileekin lankidetzan egindako argitalpenak (25)

2023

  1. m6A levels and expression of its modification genes show significant differences in breast cancer molecular subtypes

    Genes and Diseases, Vol. 10, Núm. 5, pp. 1751-1754

  2. microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

    Scientific reports, Vol. 13, Núm. 1, pp. 12159

2022

  1. In silico identification and in vitro expression analysis of breast cancer-related m6A-SNPs

    Epigenetics, Vol. 17, Núm. 13, pp. 2144-2156

2021

  1. A Novel Noninvasive Method Based on Salivary Inflammatory Biomarkers for the Screening of Celiac Disease

    Cellular and Molecular Gastroenterology and Hepatology

  2. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review

    Critical Reviews in Oncology/Hematology, Vol. 165

2019

  1. Systematic review of the potential of MicroRNAs in diffuse large B cell lymphoma

    Cancers, Vol. 11, Núm. 2

2018

  1. Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: A systematic review

    Oncotarget, Vol. 9, Núm. 32, pp. 22850-22861

2016

  1. Hereditary xerocytosis, a misleading anemia

    Annals of Hematology

  2. Lack of association of the CEP72 RS924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population

    Pharmacogenetics and Genomics, Vol. 26, Núm. 2, pp. 100-102

  3. Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia

    Pharmacogenomics, Vol. 17, Núm. 7, pp. 731-741

2015

  1. Exploring genetic factors involved in huntington disease age of onset: E2F2 as a new potential modifier gene

    PLoS ONE, Vol. 10, Núm. 7

  2. Expression of the DYRK1A gene correlates with its 3D positioning in the interphase nucleus of Down syndrome cells

    Chromosome Research, Vol. 23, Núm. 2, pp. 285-298

  3. Genetic variants in MiRNA processing genes and Pre-MiRNAs are associated with the risk of chronic lymphocytic leukemia

    PLoS ONE, Vol. 10, Núm. 3

  4. Methylation of CpG sites in BCL2 major breakpoint region and the increase of BCL2/JH translocation with aging

    Age, Vol. 37, Núm. 5

2014

  1. Errors in the interpretation of copy number variations due to the use of public databases as a reference

    Cancer Genetics, Vol. 207, Núm. 4, pp. 164-167

  2. Methylation of the nonhomologous end joining repair pathway genes does not explain the increase of translocations with aging

    Age, Vol. 36, Núm. 6

2012

  1. Bcl-2 and BLIMP-1 expression predict worse prognosis in gastric diffuse large B cell lymphoma (DLCBL) while other markers for nodal DLBCL are not useful

    Histopathology, Vol. 60, Núm. 5, pp. 785-792

2011

  1. A putative "hepitype" in the ATM gene associated with chronic lymphocytic leukemia risk

    Genes Chromosomes and Cancer, Vol. 50, Núm. 11, pp. 887-895

  2. Revisiting genome wide association studies (GWAS) in coeliac disease: Replication study in Spanish population and expression analysis of candidate genes

    Journal of Medical Genetics, Vol. 48, Núm. 7, pp. 493-496

2009

  1. High mitochondrial DNA stability in B-Cell chronic lymphocytic leukemia

    PLoS ONE, Vol. 4, Núm. 11